Literature DB >> 21473805

A précis of recent advances in the neuropsychology of mild cognitive impairment(s) in Parkinson's disease and a proposal of preliminary research criteria.

Alexander I Tröster1.   

Abstract

Cognitive changes of Parkinson's disease (PD) manifest earlier and are more heterogeneous than previously appreciated. Approximately one-third of patients have at least mild cognitive changes at PD diagnosis, and subtle changes might be appreciable among those at risk for PD. Executive dysfunction is the most common cognitive change, but other phenotypes exist. Pathobiologic and potential prognostic differences among cognitive phenotypes remain poorly understood. Progress in the neuropsychology, epidemiology and pathobiology of mild cognitive impairment (MCI) in PD is hampered by lack of diagnostic criteria. This study proposes preliminary research criteria for two categories of PD non-dementia cognitive impairment.

Entities:  

Mesh:

Year:  2011        PMID: 21473805     DOI: 10.1017/S1355617711000257

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  17 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Jennifer G Goldman; Holly Weis; Glenn Stebbins; Bryan Bernard; Christopher G Goetz
Journal:  Mov Disord       Date:  2012-07-06       Impact factor: 10.338

Review 3.  Trends and issues in characterizing early cognitive changes in Parkinson's disease.

Authors:  Daniel O Claassen; Scott A Wylie
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

4.  Cognitive phenotypes in parkinson's disease differ in terms of brain-network organization and connectivity.

Authors:  Renaud Lopes; Christine Delmaire; Luc Defebvre; Anja J Moonen; Annelien A Duits; Paul Hofman; Albert F G Leentjens; Kathy Dujardin
Journal:  Hum Brain Mapp       Date:  2016-11-17       Impact factor: 5.038

5.  N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF.

Authors:  Dan Luo; Jia Zhao; Yuanyuan Cheng; Simon Ming-Yuen Lee; Jianhui Rong
Journal:  Mol Neurobiol       Date:  2017-03-21       Impact factor: 5.590

Review 6.  Mind the gaps: What we don't know about cognitive impairment in essential tremor.

Authors:  Elan D Louis; Jillian L Joyce; Stephanie Cosentino
Journal:  Parkinsonism Relat Disord       Date:  2019-03-01       Impact factor: 4.891

Review 7.  Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2012-02-18       Impact factor: 3.575

8.  Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology.

Authors:  Mark W Bondi; Glenn E Smith
Journal:  J Int Neuropsychol Soc       Date:  2014-02-04       Impact factor: 2.892

9.  The 5 Objects Test: a novel, minimal-language, memory screening test.

Authors:  Sokratis G Papageorgiou; Alexandra Economou; Christopher Routsis
Journal:  J Neurol       Date:  2013-12-27       Impact factor: 4.849

10.  The Diagnostic Accuracy of Parkinson's Disease Mild Cognitive Impairment Battery Using the Movement Disorder Society Task Force Criteria.

Authors:  Ondrej Bezdicek; Tomas Nikolai; Jiri Michalec; Filip Růžička; Petra Havránková; Jan Roth; Robert Jech; Evžen Růžička
Journal:  Mov Disord Clin Pract       Date:  2016-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.